POM-V Prescription Required

Draxxin 25 mg/ml Solution for Injection for Pigs

Active ingredient: Tulathromycin

Form

Injection

Species

Pigs

Manufacturer

Zoetis UK Limited

VMD MA No.

42058/5022

What it's used for

Treatment and metaphylaxis of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Mycoplasma hyopneumon...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Tulathromycin

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Draxxin 25 mg/ml Solution for Injection for Pigs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Treatment and metaphylaxis of swine respiratory disease (SRD) associated with
Actinobacillus pleuropneumoniae, Pasteurella multocida, Mycoplasma
hyopneumoniae, Haemophilus parasuis and . The
presence of the disease in the group must be established before the product is used.
The veterinary medicinal product should only be used if pigs are expected to develop
the disease within 2–3 days.

Do not use in cases of hypersensitivity to macrolide antibiotics or to any of the
excipients.

Pigs:
Very common (>1 animal / 10
animals treated):
Injection site reaction
1,2
, Injection site fibrosis
,
Injection site haemorrhage
, Injection site oedema
1
Can persist for approximately 30 days after injection.
Reversible changes of congestion.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or the national competent authority via the
national reporting system. See the package leaflet for respective contact details.

Cross-resistance has been shown between tulathromycin and other macrolides in the
target pathogen(s). Use of the veterinary medicinal product should be carefully
considered when susceptibility testing has shown resistance to tulathromycin

Revised: May 2025
AN: 00099/2025
because its effectiveness may be reduced. Do not administer simultaneously with
antimicrobials with a similar mode of action such as other macrolides or
lincosamides.

Special precautions for use in animals
Use of the product should be based on identification and susceptibility testing of the
target pathogen(s). If this is not possible, therapy should be based on
epidemiological information and knowledge of susceptibility of the target pathogens
at farm level, or at local/regional level.
Use of the product should be in accordance with official, national and regional
antimicrobial policies .
An antibiotic with a lower risk of antimicrobial resistance selection (lower AMEG
category) should be used for first line treatment where susceptibility testing suggests
the likely efficacy of this approach.
If a hypersensitivity reaction occurs appropriate treatment should be administered
without delay.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Tulathromycin is irritating to eyes. In case of accidental eye exposure, flush the eyes
immediately with clean water.
Tulathromycin may cause sensitisation by skin contact resulting in e.g. reddening of
the skin (erythema) and/or dermatitis. In case of accidental spillage onto skin, wash
the skin immediately with soap and water.
Wash hands after use.
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.
If there is suspicion of a hypersensitivity reaction following accidental exposure
(recognised by e.g. itching, difficulty in breathing, hives, swelling on the face, nausea,
vomiting) appropriate treatment should be administered. Seek medical advice
immediately and show the package leaflet or the label to the physician.
Special precautions for the protection of the environment
Not applicable.
Other precautions
Not applicable.

Revised: May 2025
AN: 00099/2025

None known.

This veterinary medicinal product does not require any special storage conditions.

Meat and offal: 13 days.
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.